Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia-Reference-Cited by-同舟云学术

Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia

Published:2012-02-21 Issue:7 Volume:125 Page:911-919
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Rana Sarosh¹,Powe Camille E.¹,Salahuddin Saira¹,Verlohren Stefan¹,Perschel Frank H.¹,Levine Richard J.¹,Lim Kee-Hak¹,Wenger Julia B.¹,Thadhani Ravi¹,Karumanchi S. Ananth¹

Affiliation:

1. From the Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology (S.R., S.S., K.-H.L., S.A.K.), and Department of Medicine (S.A.K.), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; Division of Nephrology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA (C.E.P., J.B.W., R.T.); Department of Obstetrics, Campus Virchow-Clinic (S.V.), and Department of Laboratory Medicine, Clinical Chemistry, and...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Secular Trends in the Rates of Preeclampsia, Eclampsia, and Gestational Hypertension, United States, 1987-2004

2. Neonatal outcome after preterm delivery for preeclampsia

3. Practice bulletin #33: diagnosis and management of preeclampsia and eclampsia

4. Diagnosis and management of atypical preeclampsia-eclampsia

5. Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancy

Cited by 532 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The sFlt-1/PlGF-ratio and the risk of preeclampsia-related adverse outcomes in subsequent pregnancies with signs and symptoms of a preeclampsia;Pregnancy Hypertension;2024-09

2. Plasma soluble fms-like tyrosine kinase 1 to placental growth factor ratio of 11.5 multiples of median predicts preeclampsia with severe features within 2 weeks of testing;American Journal of Obstetrics and Gynecology;2024-09

3. Angiogenic Biomarkers in Preeclampsia;Obstetric Anesthesia Digest;2024-08-23

4. sFlt1/PlGF among patients with suspected preeclampsia when considering hypertensive status;AJOG Global Reports;2024-08

5. Significance of the sFlt-1/PlGF Ratio in Certain Cohorts – What Needs to be Considered?;Geburtshilfe und Frauenheilkunde;2024-07